Dupont Capital Management’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Dupont Capital Management’s Portfolio LVACW Stock Details LVACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,000	Closed	-$424	–	764
2023 Q1	$424	Hold	5,000	–	–	﹤0.01%	688
2022 Q4	$26	Hold	5,000	–	–	﹤0.01%	1379
2022 Q3	$1K	Hold	5,000	–	–	﹤0.01%	1472
2022 Q2	$1K	Hold	5,000	–	–	﹤0.01%	1600
2022 Q1	$2K	Hold	5,000	–	–	﹤0.01%	1657
2021 Q4	$3K	Buy	+5,000	New	+$2.57K	﹤0.01%	1683

Dupont Capital Management's LVACW Position: Q2 2023 in Review

Dupont Capital Management sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 5,000 shares — an estimated $424 sold.

Dupont Capital Management first reported a position in LVACW in Q4 2021 and held it in 6 quarters. The position peaked at $3K in Q4 2021. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

Dupont Capital Management reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
Dupont Capital Management sold 5,000 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $424.
Dupont Capital Management first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q4 2021 and held it in 6 quarters.
Dupont Capital Management's LAVA Medtech Acquisition Corp. Warrants position peaked at $3K in Q4 2021.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on Dupont Capital Management's 13F filing for Q2 2023, filed 25 Jul 2023.